| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499965A Bone metabolism improving agents |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1499933A Improved anti-inflammatory herbal compsn. and method of use |
| 05/26/2004 | CN1499929A Formulations comprising entrapped active ingredients and uses thereof |
| 05/26/2004 | CN1498638A Boneset drug |
| 05/26/2004 | CN1498629A Chinese traditional medicine for treating osteoporosis and its prepn. method |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151164C Prepn. of epimedium general flavone with osteoporosis resisting function |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151126C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 05/26/2004 | CN1150941C Medicine for treating rheumatism |
| 05/26/2004 | CN1150922C Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia |
| 05/26/2004 | CN1150921C Medicine for treating algia disease and its preparing process |
| 05/26/2004 | CN1150898C Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthrits, neurodermatitis and regional enterits |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740746 Nucleotide sequences coding polypeptide for use in the treatment and detection of of cancer, coronary or cerebrovascular, hypertensive, diabetic, arthritic and vision defects |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740672 Administering alosetron, tropisetron, ondansetron, granisetron and/or bemesetron |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells. |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041812A1 Therapeutic compounds and methods |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 05/21/2004 | WO2004041758A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2002060163A3 Methods for increasing bone formation and enhancing bone accretion |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2504999A1 Therapeutic compounds and methods |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097739 Ppar delta activators |
| 05/20/2004 | US20040097731 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1and tnf |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097525 Novel Compounds |
| 05/20/2004 | US20040097506 Pyrimidine derivatives for inhibition of cell proliferation |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097493 Diazinopyrimidines |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097469 For prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040097405 Method of treating cartilage damage |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096447 Preventives/remedies for thickened scar, keloid or chronic arthritic diseases |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096393 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 05/19/2004 | EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 05/19/2004 | EP1420019A1 Substituted pyridino pentaazamacrocyle ligands having superoxide dismutase activity |
| 05/19/2004 | EP1419792A1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418930A2 Mucosal repair by tff2 peptides |
| 05/19/2004 | EP1418927A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same |
| 05/19/2004 | EP1418926A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |